Trade Summary

3 days ago, Gravier Pierre, serving as CHIEF FINANCIAL OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 3,494 shares at $80.35 per share, for a total transaction value of $280,742.90. Following this transaction, Gravier Pierre now holds 83,986 shares of PTCT.

This sale represents a 3.99% decrease in Gravier Pierre's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 16, 2026 at 5:20 PM ET, 2 days after the trade was made.

PTC THERAPEUTICS, INC. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.